Drug Research
Cellceutix provides updates on clinical trials and developments of...
Cellceutix, a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, today provides shareholders with an update on the current status...
Drug Research
Mission Pharmacal introduces new oral spray for dry mouth
US-based pharmaceutical firm Mission Pharmacal has launched a new safe and effective protective oral spray called Aquoral that moistens and lubricates the mouth for up...
Drug Research
Alzheon to advance ALZ-801 into Phase II trial in...
Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical...
Drug Research
InnoCore, Allergan to develop new drug delivery products for...
Netherland-based injectable drug delivery products producer InnoCore Pharmaceuticals has signed an exclusive license and collaboration agreement with Allergan (AGN), to develop new medicines for ophthalmic...
Drug Research
Adimab, Innovent collaborate on discovery, commercialization of antibody-based therapeutic
Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab antibody discovery and optimization platform, against a selected specific target....
Drug Research
Adimab, Celgene form drug discovery partnership
Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use its proprietary discovery and optimization platform to generate fully human...
Drug Research
Supernus to launch Trokendi extended release formulation to treat...
Specialty pharmaceutical company Supernus Pharmaceuticals is set to launch once-daily extended release formulation of topiramate, Trokendi XR, to treat epilepsy following the final FDA approval....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.